Health News

Protein That Interferes With Appetite-Suppressing Hormone Identified And Blocked In Mouse Model

Date: Apr-20-2013
Ever since the appetite-regulation hormone called leptin was discovered in 1994, scientists have sought to understand the mechanisms that control its action. It was known that leptin was made by fat cells, reduced appetite and interacted with insulin , but the precise molecular details of its function - details that might enable the creation of a new treatment for obesity - remained elusive...

Health Promotion And Childhood Obesity Prevention Initiatives

Date: Apr-20-2013
More than 12 percent of preschoolers are obese, which means they have a body mass index above the 95th percentile. Among Black and Hispanic children, the figure rises to 16 percent. These early growth patterns often continue through childhood and adolescence, increasing children's health risks, which can affect almost every system in the body, from cardiovascular to mental health. Childhood obesity often occurs in the context of family obesity...

Assessing The Health And Well-Being Of Latino Youth And Families Following Implementation Of Arizona's 2010 Immigration Law

Date: Apr-20-2013
In 2010, Arizona passed an immigration law (S.B. 1070, the Support Our Law Enforcement and Safe Neighborhoods Act) that gave state police unprecedented power to detain individuals unable to prove their U.S. citizenship when asked. At a symposium during the Biennial Meeting of the Society for Research in Child Development (SRCD), researchers will examine the effect of the law on the health and well-being of Latino youth and families. Nearly 30 percent of Arizonans self-identify as Hispanic or of Latino origin, according to Census data...

Study Finds New Iodine Mouthwash�may Impact LDL Cholesterol

Date: Apr-20-2013
Clinical trials continue. Data presented to oral medicine conference Cleaning your mouth and cleaning your arteries could be as simple as a once-a-day oral rinse if additional studies confirm preliminary findings about a new product. Biomedical Development Corporation (BDC) on April 23 will present data to the American Academy of Oral Medicine showing that its oral rinse was safe and effective at fighting gingivitis in a recent clinical trial.�But the most surprising finding of the study was that users of the oral rinse showed lower LDL cholesterol levels than the placebo group...

Liver Cancers Armed With Many Strategies For Evading Immune Response

Date: Apr-20-2013
Study by Roswell Park researchers suggests approaches for overcoming resilience of hepatocellular carcinomas Researchers at Roswell Park Cancer Institute (RPCI) have published findings that help explain how a common and particularly resilient form of liver cancer evades the body's natural antitumor responses...

UCLA Researchers Find Scientific Basis For Cognitive Complaints In Post-Treatment Breast Cancer Patients

Date: Apr-20-2013
UCLA Researchers led by Dr. Patricia Ganz, director of cancer prevention and control research at the Jonsson Comprehensive Cancer Center, professor of health policy and management at the Fielding School of Public Health and professor of medicine at the David Geffen School of Medicine, have published a study showing a statistically significant association between neuropsychological (NP) test performance and memory complaints in post-treatment, early stage breast cancer patients...

Better Diagnosis Of Acute Heart Failure Using Pronota's Novel Biomarker

Date: Apr-20-2013
Two independent validation studies demonstrate that Pronota's biomarker CD146 significantly improves the diagnosis of acute heart failure for patients with shortness of breath. The biomarker, measured in blood, provides clinicians with unique additional information allowing better treatment of this challenging group of patients. Current diagnosis for acute heart failure is limited Current clinical practice for triaging patients with shortness of breath includes the measurement of specific peptides (B-type natriuretic peptides: BNP or NT-proBNP)...

Revolutionary Autoinjector Pushes The Limits Of High Viscosity Drug Delivery

Date: Apr-20-2013
Oval Medical Technologies Ltd ('Oval'), have announced that a variety of 1100 cPs solutions (the thickness of motor oil) have been successfully delivered through a 25G thin wall needle, in less than 7 seconds, using their revolutionary autoinjector. Oval is a cutting-edge autoinjector company based in Cambridge UK. Their autoinjector technology solves currently unsolvable problems in the industry for drug containment and for the end user. Oval are highly focussed and agile, and it is therefore not surprising that they are proving to be a global success and are continuously growing their team...

Details Of New Synthetic Vaccine For Emerging H7N9 Threat Revealed At BIO International Convention In Chicago, April 22-25

Date: Apr-20-2013
Replikins Ltd will reveal details on the availability of two completely synthetic vaccine candidates, both with long-term prevention goals and acute short-term blocking capacity. One of these vaccines targets H7N9 alone, the other for H7N9 plus the other common influenza strains. The company is exploring partnerships with established healthcare and pharmaceutical companies to aggressively commercialize the technology...

Breast Pain Issue For One In Three Female Marathon Runners

Date: Apr-20-2013
Pain more common among larger breasted women but sports bras don't always help One in three female marathon runners is likely to suffer breast pain (mastalgia) during the course of the event, suggests research published online in the British Journal of Sports Medicine. Women with larger cup sizes seem to be more susceptible, but childless women also seem to be more prone, and wearing a sports bra doesn't always help, finds the study, which publishes as London gears up for its annual international marathon tomorrow...